Your browser doesn't support javascript.
loading
Myeloid cell reprogramming alleviates immunosuppression and promotes clearance of metastatic lesions.
Raghani, Ravi M; Ma, Jeffrey A; Zhang, Yining; Orbach, Sophia M; Wang, Jing; Zeinali, Mina; Nagrath, Sunitha; Kakade, Sandeep; Xu, Qichen; Podojil, Joseph R; Murthy, Tushar; Elhofy, Adam; Jeruss, Jacqueline S; Shea, Lonnie D.
Afiliación
  • Raghani RM; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
  • Ma JA; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
  • Zhang Y; Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.
  • Orbach SM; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
  • Wang J; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
  • Zeinali M; Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.
  • Nagrath S; Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.
  • Kakade S; COUR Pharmaceuticals Development Co, Inc, Northbrook, IL, United States.
  • Xu Q; COUR Pharmaceuticals Development Co, Inc, Northbrook, IL, United States.
  • Podojil JR; COUR Pharmaceuticals Development Co, Inc, Northbrook, IL, United States.
  • Murthy T; Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
  • Elhofy A; COUR Pharmaceuticals Development Co, Inc, Northbrook, IL, United States.
  • Jeruss JS; COUR Pharmaceuticals Development Co, Inc, Northbrook, IL, United States.
  • Shea LD; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.
Front Oncol ; 12: 1039993, 2022.
Article en En | MEDLINE | ID: mdl-36479083

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article